Company / Current Assets
Structure Therapeutics Inc. Current Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.6B
FY2025
5-year range
$93.1M / $1.6B
FY2022-FY2025
Trend
+76.2%
vs FY2024
Sector context
#37 of 213
Health Care
What the data says
Structure Therapeutics Inc.'s current assets of $1.6B is higher than 83% of companies in the Health Care sector (FY2025). Current Assets has increased for 3 consecutive years, from $93M in FY2022 to $1.6B in FY2025.
Based on SEC 10-K filings.
$1.6B in FY2025 with a 3-year CAGR of +156.5%. Top quartile in the Health Care sector.
Improved from $474M to $1.6B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +156.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 213This company $1.6B Sector average $2.5B
▼
-37.8% below sector average
Key checks
Key Insights
- Structure Therapeutics Inc.'s current assets has grown for 3 consecutive years.
- 3-year CAGR of +156.5%, indicating consistent growth.
- In FY2025, current assets increased 76.2% year-over-year.
- Ranks #37 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 9.77 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.6B | +76.2% |
| FY2024 | $891.2M | +88.2% |
| FY2023 | $473.6M | +408.8% |
| FY2022 | $93.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026